CD8A and prostate neoplasm: We previously demonstrated that in in vitro co-culture models between prostate tumor cells and PBMC, UMCD6 augmented killing of LNCaP and PC3 prostate cancer cell lines through direct activation of NK and CD8 + T cells [7].